The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for venetoclax (Abbvie Pty Ltd)
Active ingredients
venetoclax
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet, film-coated
Indication
Venetoclax is indicated for the treatment of patients with acute myeloid leukaemia (AML)
Therapeutic area
Haematology